Deep Breath Intelligence (DBI), a MedTech company unleashing the huge potential of exhaled breath analysis through machine learning, has selected HTEC Group and Effectum Medical as primary innovation …
ZÜRICH, May 11, 2021 /PRNewswire/
The 21 organizations participating at BIO Digital s Swiss Pavilion demonstrate the enduring strength and rich diversity of the country s life science ecosystem. 2021 marks the 15
th consecutive year that there has been a pavilion at BIO. Switzerland Global Enterprise along with their partners Presence Switzerland, Innosuisse, Switzerland Innovation, Swiss Business Hub USA and Swiss Biotech Association will be represented at the virtual booth in addition to eight Innosuisse startups exemplifying an exciting new generation focused on delivering the promise of personalized medicine.
Despite the COVID-19 pandemic, global companies have continued to expand their operations in Switzerland, while the startup scene has remained vibrant. Switzerland has ranked top in the Global Innovation Index for each of the past 10 years, life science exports have grown by a factor of 4.5 since 2000, and now account for 44% of total Swiss exports. From 2019 to 20
Guest Author April 15, 2021
New companies are leading the way.
Deep Breath Intelligence, a spin-off from some of the top Swiss universities, is using artificial intelligence to uncover the full potential of Molecular Breath Analysis for precision medicine applications. Diaxxo, founded in 2020 at ETH Zurich, has developed simple and precise Point-of-Care PCR test to help doctors identify and treat diseases faster.
Saverna Therapeutics, a company that is just 4 years old, is using the latest artificial intelligence tools and Nuclear Magnetic Resonance to reduce the time and cost of drug discovery.
Established companies that are synonymous with Switzerland, such as
Novartis, are also playing a vital role in helping to foster this innovation. Just last year,